Oxford Cannabinoid Technologies Holdings Plc
🇬🇧United Kingdom
Clinical Trials
1
Active:0
Completed:1
Trial Phases
1 Phases
Phase 1:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 1
1 (100.0%)Single Ascending Oral Dose Study to Investigate the Effects of OCT461201 in Healthy Volunteers
Phase 1
Completed
- Conditions
- Healthy
- Interventions
- Drug: OCT461201 100 mgDrug: OCT461201 150 mgDrug: OCT461201 450 mgDrug: OCT461201 50 mgDrug: Placebo
- First Posted Date
- 2024-05-03
- Last Posted Date
- 2024-05-03
- Lead Sponsor
- Oxford Cannabinoid Technologies Holdings PLC
- Target Recruit Count
- 32
- Registration Number
- NCT06398925
- Locations
- 🇬🇧
Simbec-Orion, Merthyr Tydfil, United Kingdom
News
No news found